Biggest News Aggregation in the World
📰 Forward Looking Statements News

Page 77 - Forward Looking Statements News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Forward Looking Statements. Real-time updates on events, politics, business and more.

RF Industries, Ltd. (NASDAQ:RFIL) Q4 2023 Earnings Call Transcript

RF Industries, Ltd. (NASDAQ:RFIL) Q4 2023 Earnings Call Transcript January 23, 2024 RF Industries, Ltd. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.04. RFIL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
Stocks To Buy Medical Specialties Rf Industries Cf Industries Fourth Quarter Bob Dawson
Source: yahoo.com

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for...
France General Corentine Driancourt Tarik Elgoutni Naimish Patel Regeneron Velocimmune Vesna Tosic

Press Release: Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis (EoE) -January 25, 2024 at 02:31 pm EST

Dupixent® FDA approved as first and only treatment indicated for children aged 1 year and older with eosinophilic esophagitis  Approval based on Phase 3 EoE KIDS trial showing a greater...
France General Evan Berland Ilana Yellen Naimish Patel Corentine Driancourt Eva Schaefer Jansen

Ultragenyx Announces Completion of Dosing Across Stage 1 Cohorts in Pivotal Phase 1/2/3 Cyprus2+ Study Evaluating UX701 Gene Therapy for the Treatment of Wilson Disease

Safety and initial efficacy data from Stage 1 expected in the first half of 2024 Dose selection and initiation of Stage 2 to follow in the second half of 2024 NOVATO, Calif., Jan. 25, 2024 --...
Carolyn Wang Eric Crombez Joshua Higa Drug Administration Ultragenyx Pharmaceutical Inc Exchange Commission

Dupixent® (dupilumab) FDA Approved as First and Only Treatment Indicated for Children Aged 1 Year and Older with Eosinophilic Esophagitis (EoE)

Approval based on Phase 3 EoE KIDS trial showing a greater proportion of children taking Dupixent achieved histological remission compared to placebo Expanded indication marks second disease for...
France General Sally Bain Regeneron Velocimmune Tarik Elgoutni Felix Lauscher Arnaud Delepine

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Dundee Precious Metals Files Technical Report on the ?oka Rakita Gold Project

Dundee Precious Metals Inc. today announced that the Company has filed a technical report for its ?oka Rakita gold project in Serbia. The purpose of the report was to support the maiden Mineral Resource estimate for ?oka Rakita, as previously... - Veroeffentlicht am 24.01.2024
Jennifer Cameron David Rae Company Forward Looking Toronto Stock Exchange Dundee Precious Metals Inc Canadian Securities Administrator National Instrument

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science